verapamil has been researched along with Glycogen Storage Disease Type V in 2 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Glycogen Storage Disease Type V: Glycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo." | 9.06 | A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986) |
| "Eleven patients, comprising three cases of McArdle's disease and eight with an exertional muscle pain syndrome (EMPS) of unknown cause, entered a double-blind crossover study of verapamil and placebo." | 5.06 | A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain. ( Lane, RJ; Turnbull, DM; Walton, J; Welch, JL, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, RJ | 2 |
| Turnbull, DM | 2 |
| Hudgson, P | 1 |
| Walton, J | 2 |
| Welch, JL | 1 |
2 trials available for verapamil and Glycogen Storage Disease Type V
| Article | Year |
|---|---|
Trials of verapamil and dantrolene sodium in McArdle disease.
Topics: Calcium; Clinical Trials as Topic; Dantrolene; Glycogen Storage Disease; Glycogen Storage Disease Ty | 1984 |
A double-blind, placebo-controlled, crossover study of verapamil in exertional muscle pain.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Female; Glycogen Storage Disease; Glycogen Sto | 1986 |